Detection of colorectal adenoma and cancer based on transthyretin and C3a-desArg serum levels

Proteomics - Clinical Applications

Volumn 1, Issue 6, 2007, Pages 536-544

  Fentz, Anne Kristin ^a   Spörl, Monika ^a   Spangenberg, Jörg ^a   List, Heinz Joachim ^a   Zornig, Carsten ^b   Dörner, Arnulf ^c   Layer, Peter ^b   Juhl, Hartmut ^a   David, Kerstin A ^a  

^a Indivumed GmbH   (Germany)

^b ISRAELITISCHES KRANKENHAUS   (Germany)

^c Department of Surgery   (Germany)

Author keywords

Colorectal adenoma; Colorectal cancer; Pre albumin; SELDI TOF MS; Transthyretin

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT COMPONENT C3A DESARGININE; PREALBUMIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 38149120824     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200600664     Document Type: Article

References (29)

1. US Cancer Statistics Working Group, United States Cancer Statistics: 1999-2002 Incidence and Mortality, US Department of Health and Human Services, CDC, National Cancer Institute, Atlanta, GA 2005.
2. Gryfe, R., Swallow, C., Bapat, B., Redston, M. et al., Curr. Probl. Cancer 1997, 21, 233-300.
3. Goyette, M. C., Cho, K., Fasching, C. L., Levy, D. B. et al., Mol. Cell. Biol. 1992, 12, 1387-1395.
4. Link, K. H., Sagban, T. A., Morschel, M., Tischbirek, K. et al., Langenbecks Arch. Surg. 2005, 390, 83-93.
5. Demols, A., Van Laethem, J. L., Curr. Gastroenterol. Rep. 2002, 4, 420-426.
6. Vernon, S. W., J. Natl. Cancer Inst. 1997, 89, 1406-1422.
7. Frazier, A. L., Colditz, G. A., Fuchs, C. S., Kuntz, K. M. et al., JAMA 2000, 284, 1954-1961.
8. Schapira, M., Adler, M., Acta Gastroenterol. Belg. 2005, 68, 251-256.
9. Yang, S. Y., Xiao, X. Y., Zhang, W. G., Zhang, L. J. et al., BMC Cancer 2005, 5, 83.
10. Zhang, Z., Bast, R. C. Jr., Yu, Y. et al., Cancer Res. 2004, 64, 5882-5890.
11. Melle, C., Osterloh, D., Ernst, G. et al., Int. J. Mol. Med. 2005, 16, 11-17.
12. Petricoin, E. F., Ardekani, A. M., Hitt, B. A. et al., Lancet 2002, 359, 572-577.
13. Petricoin, E. F., 3rd, Ornstein, D. K., Paweletz, C. P. et al., J. Natl. Cancer Inst. 2002, 94, 1576-1578.
14. Kwapiszewska, G., Meyer, M., Bogumil, R., Bohle, R. M. et al., BMC Biotechnol. 2004, 4, 30.
15. Hanley, J. A., McNeil, B. J., Radiology 1982, 143, 29-36.
16. Schweigert, F. J., Wirth, K., Raila, J., Proteome Sci. 2004, 2, 5.
17. Zwirner, J., Werfel, T., Wilken, H. C., Theile, E. et al., Eur. J. Immunol. 1998, 28, 1570-1577.
18. Cianflone, K., Xia, Z., Chen, L. Y., Biochim. Biophys. Acta. 2003, 1609, 127-143.
19. Bernstein, L. H., Ingenbleek, Y., Clin. Chem. Lab. Med. 2002, 40, 1344-1348.
20. Pleban, W. E., Conn. Med. 1989, 53, 405-407.
21. Straus, D. S., Clin. Chem. Lab. Med. 2002, 40, 1274-1280.
22. Milano, G., Cooper, E. H., Goligher, J. C. et al., J. Natl. Cancer Inst. 1978, 61, 687-691.
23. Mahlck, C. G., Grankvist, K., Gynecol. Obstet. Invest. 1994, 37, 135-140.
24. Suresh, U. R., Wilkes, S., Hasleton, P. S., J. Clin. Pathol. 1991, 44, 573-575.
25. Benvenga, S., Bartalena, L., Antonelli, A., Li Calzi, L. et al., Ann. Clin. Lab. Sci. 1986, 16, 231-240.
26. Joelsson, B., Alwmark, A., Gullstrand, P., Bengmark, S. et al., J. Clin. Chem. Biochem. 1987, 25, 865-868.
27. Verhaegen, H., De Cock, W., De Cree, J., Verbruggen, F., Cancer 1976, 38, 1608-1613.
28. Kozak, K. R., Su, F., Whitelegge, J. P., Faull, K. et al., Proteomics 2005, 5, 4589-4596.
29. Orchekowski, R., Hamelinck, D., Li, L., Gliwa, E. et al., Cancer Res. 2005, 65, 11193-11202.